Company intelligence / Profile preview

Yongjin Group

Beijing / Shanghai / n.a., Beijing Municipality / Shanghai Municipality / Zhejiang Province*, China

Ownership: Private
Development stage: Other

Overview

Yongjin Group is primarily an investment and financial services holding company based in China, with significant activities in private equity and venture capital. It has made investments across several sectors including the pharmaceutical industry, but does not itself develop drugs or own therapeutic platforms. Its portfolio includes companies such as ITabMed and TechsoMed, which are active in life sciences.

Industry: Investors

Beyond the preview

Go deeper on Yongjin Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yongjin Group.

Explore the full profile